{"id":"https://openalex.org/W4361954147","doi":"https://doi.org/10.1158/1078-0432.c.6532368","title":"Data from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial","display_name":"Data from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361954147","doi":"https://doi.org/10.1158/1078-0432.c.6532368"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6532368","doi":"https://doi.org/10.1158/1078-0432.c.6532368","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6532368","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6532368","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076426660","display_name":"Funda Meric\u2010Bernstam","orcid":"https://orcid.org/0000-0001-6816-6072","observed_orcids":["https://orcid.org/0000-0001-6816-6072"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Funda Meric-Bernstam","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":"https://orcid.org/0000-0001-6816-6072","affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058115259","display_name":"Nizar M. Tannir","orcid":"https://orcid.org/0000-0001-5559-8060","observed_orcids":["https://orcid.org/0000-0001-5559-8060"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nizar M. Tannir","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038992904","display_name":"Othon Iliopoulos","orcid":"https://orcid.org/0000-0002-4444-6157","observed_orcids":["https://orcid.org/0000-0002-4444-6157"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Othon Iliopoulos","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039517650","display_name":"Richard J. Lee","orcid":"https://orcid.org/0000-0001-9949-671X","observed_orcids":["https://orcid.org/0000-0001-9949-671X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard J. Lee","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, Massachusetts"],"raw_orcid":"https://orcid.org/0000-0001-9949-671X","affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052487618","display_name":"Melinda L. Telli","orcid":"https://orcid.org/0000-0001-7993-1235","observed_orcids":["https://orcid.org/0000-0001-7993-1235"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melinda L. Telli","raw_affiliation_strings":["Stanford University School of Medicine, Stanford, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University School of Medicine, Stanford, California","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028169162","display_name":"Alice C. Fan","orcid":"https://orcid.org/0000-0002-4813-5444","observed_orcids":["https://orcid.org/0000-0002-4813-5444"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alice C. Fan","raw_affiliation_strings":["Stanford University School of Medicine, Stanford, California"],"raw_orcid":"https://orcid.org/0000-0002-4813-5444","affiliations":[{"raw_affiliation_string":"Stanford University School of Medicine, Stanford, California","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005537242","display_name":"Angela M. DeMichele","orcid":"https://orcid.org/0000-0003-1297-4251","observed_orcids":["https://orcid.org/0000-0003-1297-4251"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela DeMichele","raw_affiliation_strings":["Penn Medicine Abramson Cancer Center, Philadelphia, Pennsylvania"],"raw_orcid":"https://orcid.org/0000-0003-1297-4251","affiliations":[{"raw_affiliation_string":"Penn Medicine Abramson Cancer Center, Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I4390039297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046123003","display_name":"Naomi Balzer Haas","orcid":"https://orcid.org/0000-0001-8907-7968","observed_orcids":["https://orcid.org/0000-0001-8907-7968"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naomi B. Haas","raw_affiliation_strings":["Penn Medicine Abramson Cancer Center, Philadelphia, Pennsylvania"],"raw_orcid":"https://orcid.org/0000-0001-8907-7968","affiliations":[{"raw_affiliation_string":"Penn Medicine Abramson Cancer Center, Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I4390039297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005718112","display_name":"Manish R. Patel","orcid":"https://orcid.org/0000-0001-6836-2364","observed_orcids":["https://orcid.org/0000-0001-6836-2364"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manish R. Patel","raw_affiliation_strings":["Florida Cancer Specia-lists/Sarah Cannon Research Institute, Sarasota, Florida"],"raw_orcid":"https://orcid.org/0000-0001-6836-2364","affiliations":[{"raw_affiliation_string":"Florida Cancer Specia-lists/Sarah Cannon Research Institute, Sarasota, Florida","institution_ids":["https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065435809","display_name":"James J. Harding","orcid":"https://orcid.org/0000-0002-7029-4310","observed_orcids":["https://orcid.org/0000-0002-7029-4310","https://orcid.org/0000-0003-0766-9965"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James J. Harding","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York"],"raw_orcid":"https://orcid.org/0000-0002-7029-4310","affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091859782","display_name":"Martin Henner Voss","orcid":"https://orcid.org/0000-0003-0551-5807","observed_orcids":["https://orcid.org/0000-0003-0551-5807"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin H. Voss","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York"],"raw_orcid":"https://orcid.org/0000-0003-0551-5807","affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015060656","display_name":"Taofeek Kunle Owonikoko","orcid":"https://orcid.org/0000-0002-7724-7728","observed_orcids":["https://orcid.org/0000-0002-7724-7728"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taofeek K. Owonikoko","raw_affiliation_strings":["Emory University Winship Cancer Center, Atlanta, Georgia"],"raw_orcid":"https://orcid.org/0000-0002-7724-7728","affiliations":[{"raw_affiliation_string":"Emory University Winship Cancer Center, Atlanta, Georgia","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035665916","display_name":"Bradley Curtis Carthon","orcid":"https://orcid.org/0000-0002-9176-8538","observed_orcids":["https://orcid.org/0000-0002-9176-8538"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradley Carthon","raw_affiliation_strings":["Emory University Winship Cancer Center, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University Winship Cancer Center, Atlanta, Georgia","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031748968","display_name":"Ramaprasad Srinivasan","orcid":"https://orcid.org/0000-0001-6392-3169","observed_orcids":["https://orcid.org/0000-0001-6392-3169"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramaprasad Srinivasan","raw_affiliation_strings":["National Cancer Institute at the NIH, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute at the NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028472820","display_name":"Johanna C. Bendell","orcid":"https://orcid.org/0000-0001-9426-5891","observed_orcids":["https://orcid.org/0000-0001-9426-5891"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Johanna C. Bendell","raw_affiliation_strings":["Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee","institution_ids":["https://openalex.org/I4210100810","https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008883146","display_name":"Yonchu Jenkins","orcid":"https://orcid.org/0009-0000-1917-9248","observed_orcids":["https://orcid.org/0009-0000-1917-9248"]},"institutions":[{"id":"https://openalex.org/I4210115323","display_name":"Calithera (United States)","ror":"https://ror.org/029gt5q28","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115323"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yonchu Jenkins","raw_affiliation_strings":["Calithera Biosciences, Inc., South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Calithera Biosciences, Inc., South San Francisco, California","institution_ids":["https://openalex.org/I4210115323"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013695327","display_name":"Sam H. Whiting","orcid":"https://orcid.org/0009-0000-8736-0583","observed_orcids":["https://orcid.org/0009-0000-8736-0583"]},"institutions":[{"id":"https://openalex.org/I4210115323","display_name":"Calithera (United States)","ror":"https://ror.org/029gt5q28","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115323"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sam H. Whiting","raw_affiliation_strings":["Calithera Biosciences, Inc., South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Calithera Biosciences, Inc., South San Francisco, California","institution_ids":["https://openalex.org/I4210115323"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109262452","display_name":"Keith William Orford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115323","display_name":"Calithera (United States)","ror":"https://ror.org/029gt5q28","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115323"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith Orford","raw_affiliation_strings":["Calithera Biosciences, Inc., South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Calithera Biosciences, Inc., South San Francisco, California","institution_ids":["https://openalex.org/I4210115323"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055304416","display_name":"Mark K. Bennett","orcid":"https://orcid.org/0000-0003-1046-1292","observed_orcids":["https://orcid.org/0000-0003-1046-1292"]},"institutions":[{"id":"https://openalex.org/I4210115323","display_name":"Calithera (United States)","ror":"https://ror.org/029gt5q28","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115323"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark K. Bennett","raw_affiliation_strings":["Calithera Biosciences, Inc., South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Calithera Biosciences, Inc., South San Francisco, California","institution_ids":["https://openalex.org/I4210115323"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037195922","display_name":"Todd Michael Bauer","orcid":"https://orcid.org/0000-0002-3078-5043","observed_orcids":["https://orcid.org/0000-0002-3078-5043"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd M. Bauer","raw_affiliation_strings":["Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee","institution_ids":["https://openalex.org/I4210100810","https://openalex.org/I4210135086"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.006300000008195639,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/telaglenastat","display_name":"telaglenastat","score":0.996999979019165},{"id":"https://openalex.org/keywords/cabozantinib","display_name":"cabozantinib","score":0.9869999885559082},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":1.0},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9340000152587891},{"id":"https://openalex.org/keywords/glutaminase-inhibitors","display_name":"glutaminase inhibitors","score":0.7710000276565552},{"id":"https://openalex.org/keywords/glucose-metabolism-inhibition","display_name":"glucose metabolism inhibition","score":0.7979999780654907},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8320000171661377},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8450000286102295},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7870000004768372},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8330000042915344},{"id":"https://openalex.org/keywords/clear-cell-renal-cell-carcinoma","display_name":"clear cell renal cell carcinoma","score":0.8420000076293945},{"id":"https://openalex.org/keywords/papillary-renal-cell-carcinoma","display_name":"papillary renal cell carcinoma","score":0.9980000257492065}],"concepts":[{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.7837740778923035},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7807823419570923},{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.6293217539787292},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6201654672622681},{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.6141067743301392},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.6113688349723816},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5946728587150574},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5469477772712708},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.4100792407989502},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32785069942474365}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.c.6532368","doi":"https://doi.org/10.1158/1078-0432.c.6532368","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6532368","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.c.6532368.v1","doi":"https://doi.org/10.1158/1078-0432.c.6532368.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6532368.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6532368","doi":"https://doi.org/10.1158/1078-0432.c.6532368","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6532368","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1197969595","display_name":"Center for Clinical and Translational Sciences (CCTS)","funder_award_id":"UL1TR003167","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G1468253849","display_name":null,"funder_award_id":"(CA016672)","funder_id":"https://openalex.org/F4320332521","funder_display_name":"University of Texas MD Anderson Cancer Center"},{"id":"https://openalex.org/G293715275","display_name":null,"funder_award_id":"P30-CA-016672","funder_id":"https://openalex.org/F4320332521","funder_display_name":"University of Texas MD Anderson Cancer Center"},{"id":"https://openalex.org/G8280086477","display_name":null,"funder_award_id":"1UL1TR003167","funder_id":"https://openalex.org/F4320332521","funder_display_name":"University of Texas MD Anderson Cancer Center"},{"id":"https://openalex.org/G9000289527","display_name":null,"funder_award_id":"CA016672","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000878657","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016672","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320317547","display_name":"Calithera Biosciences","ror":"https://ror.org/029gt5q28"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332521","display_name":"University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W2019607817","https://openalex.org/W2152057203","https://openalex.org/W2158294624","https://openalex.org/W2237254160","https://openalex.org/W2415950182","https://openalex.org/W2433976232","https://openalex.org/W2604077136","https://openalex.org/W2914788991","https://openalex.org/W4237816489"],"related_works":["https://openalex.org/W4211061257","https://openalex.org/W4280497867","https://openalex.org/W4361948078","https://openalex.org/W4294000513","https://openalex.org/W3168718184","https://openalex.org/W2978044081","https://openalex.org/W4410299363","https://openalex.org/W2891117787","https://openalex.org/W2794427449","https://openalex.org/W2920893660"],"abstract_inverted_index":{"AbstractPurpose:":[0],"Dual":[1],"inhibition":[2],"of":[3,63,188,196],"glucose":[4,47],"and":[5,56,105,119,141,145,151,167,225,250,256],"glutamine":[6],"metabolism":[7,48],"results":[8],"in":[9,13,27,49,72,245,258],"synergistic":[10],"anticancer":[11],"effects":[12],"solid":[14],"tumor":[15],"models.":[16],"Telaglenastat,":[17],"an":[18],"investigational,":[19],"small-molecule,":[20],"glutaminase":[21],"inhibitor,":[22],"exhibits":[23],"modest":[24],"single-agent":[25],"activity":[26,255],"renal":[28],"cell":[29,223],"carcinoma":[30],"(RCC)":[31],"patients.":[32,262],"This":[33],"phase":[34,185],"Ib":[35],"trial":[36],"evaluated":[37],"telaglenastat":[38,64,190],"plus":[39,78],"cabozantinib":[40,87],"or":[41,86,198],"everolimus,":[42],"agents":[43],"known":[44],"to":[45,131,182],"impair":[46],"patients":[50,59,110,220],"with":[51,116,143,153,165,169,193,221],"metastatic":[52],"RCC":[53],"(mRCC).":[54],"Patients":[55],"Methods:":[57],"mRCC":[58,261],"received":[60,111,114],"escalating":[61],"doses":[62,195],"[400\u2013800":[65],"mg":[66,82,89],"per":[67,159],"os":[68],"(p.o.)":[69],"twice":[70,191],"daily]":[71],"a":[73,183],"3":[74,76,120,162],"+":[75,207],"design,":[77],"either":[79,179],"everolimus":[80],"(10":[81],"daily":[83,90,192],"p.o.;":[84,91],"TelaE)":[85],"(60":[88],"TelaC).":[92],"Tumor":[93],"response":[94,205,216,242],"(RECISTv1.1)":[95],"was":[96,176,210,232],"assessed":[97],"every":[98],"8":[99],"weeks.":[100],"Endpoints":[101],"included":[102],"safety":[103],"(primary)":[104],"antitumor":[106],"activity.":[107],"Results:":[108],"Twenty-seven":[109],"TelaE,":[112,144],"13":[113],"TelaC,":[115],"median":[117],"2":[118],"prior":[121],"therapies,":[122],"respectively.":[123],"Treatment-related":[124],"adverse":[125],"events":[126],"were":[127],"mostly":[128],"grades":[129],"1":[130,214],"2,":[132],"most":[133],"common":[134],"including":[135,213],"decreased":[136,147],"appetite,":[137,148],"anemia,":[138],"elevated":[139,149],"transaminases,":[140,150],"diarrhea":[142],"diarrhea,":[146],"fatigue":[152],"TelaC.":[154,170],"One":[155],"dose-limiting":[156],"toxicity":[157],"occurred":[158],"cohort:":[160],"grade":[161],"pruritic":[163],"rash":[164],"TelaE":[166,200,249],"thrombocytopenia":[168],"No":[171],"maximum":[172],"tolerated":[173],"dose":[174,187],"(MTD)":[175],"reached":[177],"for":[178,228,235],"combination,":[180],"leading":[181],"recommended":[184],"II":[186],"800-mg":[189],"standard":[194],"E":[197],"C.":[199],"disease":[201],"control":[202],"rate":[203,206],"(DCR;":[204],"stable":[208],"disease)":[209],"95.2%":[211],"[20/21,":[212],"partial":[215],"(PR)]":[217],"among":[218],"21":[219],"clear":[222,246],"histology":[224],"66.7%":[226],"(2/3)":[227],"papillary.":[229],"TelaC":[230,251],"DCR":[231],"100%":[233],"(12/12)":[234],"both":[236],"histologies":[237],"[5/10":[238],"PRs":[239],"as":[240],"best":[241],"(3":[243],"confirmed)":[244],"cell].":[247],"Conclusions:":[248],"showed":[252],"encouraging":[253],"clinical":[254],"tolerability":[257],"heavily":[259],"pretreated":[260]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2023-04-05T00:00:00"}